Unibail-Rodamco-Westfield SE (ASX:URW)

Verve Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	21,575	17,351	15,088	10,611	13,358	14,179
Market Cap Growth	26.54%	15.00%	42.19%	-20.56%	-5.79%	-54.39%
Enterprise Value	68,260	63,262	59,689	56,061	60,672	63,759
Last Close Price	7.49	5.74	4.99	3.57	4.41	4.71
PE Ratio	15.60	70.94	-	37.87	-	-
PS Ratio	3.33	3.15	3.22	2.29	4.38	9.00
PB Ratio	0.58	0.49	0.45	0.29	0.38	0.39
P/OCF Ratio	-	4.74	4.53	2.77	4.96	6.28
EV/Sales Ratio	10.56	11.49	12.73	12.08	19.90	40.47
EV/EBITDA Ratio	16.04	18.94	24.26	22.41	53.29	-
EV/EBIT Ratio	17.09	20.13	24.85	22.41	59.41	-
Debt / Equity Ratio	1.22	1.35	1.38	1.20	1.26	1.31
Debt / EBITDA Ratio	10.71	14.12	18.74	17.12	38.09	-
Asset Turnover	0.07	0.06	0.05	0.05	0.04	0.02
Inventory Turnover	41.29	45.74	29.58	27.34	31.21	18.86
Quick Ratio	0.87	1.23	1.75	1.64	0.95	0.69
Current Ratio	0.93	1.38	1.81	1.66	1.05	0.91
Return on Equity (ROE)	4.89%	1.33%	-8.14%	1.27%	-4.39%	-28.09%
Return on Assets (ROA)	2.68%	2.19%	1.71%	1.81%	0.73%	-0.39%
Return on Capital (ROIC)	2.92%	2.38%	1.85%	1.97%	0.79%	-0.42%
Earnings Yield	6.41%	1.41%	-17.51%	2.64%	-11.38%	-80.66%
Dividend Yield	4.11%	101.92%	81.24%	-	-	-
Payout Ratio	3.18%	305.54%	-	26.99%	-	-
Buyback Yield / Dilution	-2.90%	-1.55%	0.35%	-0.65%	-0.08%	1.44%
Total Shareholder Return	1.24%	100.37%	81.59%	-0.65%	-0.08%	1.44%

Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.